Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
International Journal of Oncology|October 19, 2012
BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cellsHong-Quan Duong, Jae Seok Hwang, Hee Jeong Kim, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast CancerKyu Sic You, Yong Weon Yi, Jeonghee Cho, et al.
Antioxidants (Basel, Switzerland)|July 4, 2017
Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer CellsHong-Quan Duong, Kyu Sic You, Seunghoon Oh, et al.
International Journal of Molecular Sciences|January 11, 2022
Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?Yong Weon Yi, Kyu Sic You, Jeong-Soo Park, et al.
American Journal of Cancer Research|August 6, 2021
Doxycycline potentiates the anti-proliferation effects of gemcitabine in pancreatic cancer cellsYong Weon Yi, Na Young Park, Joo-In Park, et al.
International Journal of Oncology|May 9, 2015
Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6Yong Weon Yi, Kyusic You, Edward Jeong Bae, et al.
Experimental & Molecular Medicine|February 28, 2015
β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cellsYong Weon Yi, Hyo Jin Kang, Edward Jeong Bae, et al.
Molecular and Cellular Biology|March 7, 2007
Functional importance of the anaphase-promoting complex-Cdh1-mediated degradation of TMAP/CKAP2 in regulation of spindle function and cytokinesisKyung Uk Hong, Young Soo Park, Yeon-Sun Seong, et al.
International Journal of Oncology|June 20, 2012
Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cellsHong-Quan Duong, Jae Seok Hwang, Hee Jeong Kim, et al.
American Journal of Cancer Research|February 14, 2025
Identification of sinensetin as a selective inhibitor for mitogen-activated protein kinase kinase 6 and an anticancer agent for non-small cell lung cancerXiaomeng Xie, Young Ran Shin, Tae-Sung Kim, et al.
Pageof 5